The Michael J. Fox Foundation
From: The Michael J. Fox Foundation
Sent: Thursday, December 21, 2017 3:40 PM
To: [log in to unmask]
Subject: Breaking News: Important Clinical Study Announces Positive Results
View this email as a webpage | Add [log in to unmask] to your address book | Contact Us
Last night, the biotech company conducting the first-ever clinical trial of a Parkinson's treatment targeting LRRK2 announced good news. This early study has reported positive results, showing that the experimental treatment is safe and exerts the desired effect in body cells, setting the stage for future trials. Clinical testing will continue in patients who carry the LRRK2 mutation. The company's CEO has been forthcoming with his acknowledgment of our Foundation's partnership in helping bring LRRK2 to this point.
LRRK2 is one of the most promising targets in Parkinson's disease, with potential to slow or stop progression of the disease (something no current treatment can do). It has been the subject of intensive investigation fieldwide, and millions of dollars in grants from our Foundation, since its discovery in 2004.
It is our privilege to share this news with you, the patients and families relying on us to drive meaningful progress in Parkinson's research. Your commitment to our mission makes it possible for us to work with the researchers on the front lines of accelerating the breakthroughs patients need. Please consider making a gift, or renewing your support, today. Thank you for all you do.
With warmest wishes for a joyous holiday season and a bright New Year,
The Michael J. Fox Foundation for Parkinson's Research
This email was sent to [log in to unmask]
This email was sent by:
The Michael J. Fox Foundation
Grand Central Station, P.O. Box 4777
New York, NY 10163-4777
1-800-708-7644
We respect your right to privacy - view our policy
Manage My Preferences
----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn
